Farrow Jeffrey S Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$465,230.57

Insider Activity of Farrow Jeffrey S

According to the SEC Form 4 filings, Farrow Jeffrey S, being in a position of

  1. See Remarks at Tarsus Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 20826 shares for $1.32M,
    over all time since 2024-06-18, has bought 0 shares, and sold 48603 shares for $2.33M.

Biography of Farrow Jeffrey S

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,317,0024100

Comparison of Insiders on Amount of Buys and Sells

2026-06-16SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
14,396
0.0335%
$60.95$877,436+16.38%
2026-03-19SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
2,186
0.0052%
$67.00$146,462+0.38%
2026-03-18SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
2,133
0.005%
$68.71$146,558-1.88%
2026-03-17SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
2,111
0.0049%
$69.42$146,546-3.99%
2025-06-17SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
13,608
0.0332%
$40.42$550,035+64.99%
2025-03-20SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
1,186
0.0029%
$50.11$59,430+15.47%
2025-03-19SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
1,254
0.0029%
$47.40$59,440+15.9%
2025-03-18SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
1,284
0.0031%
$46.29$59,436+24.19%
2024-06-18SaleTarsus Pharmaceuticals, Inc.
TARS
See Remarks
10,445
0.0233%
$27.47$286,924+63.07%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.